Arrowstreet Capital Limited Partnership Has $669.01 Million Stock Position in Bristol Myers Squibb Company $BMY

NodeGuardian · 2026-03-17T08:55:35+00:00

Arrowstreet Capital increased its Bristol Myers Squibb stake by 31.1%, owning 14.8 million shares worth $669.01 million. Institutional ownership stands at 76.41%. The article discusses stock performance, earnings, dividends, and mixed analyst ratings, with a consensus "Hold" and a price target of $61.00.

NodeGuardian

2026-03-17 08:55:35

Abstract generation in progress

Arrowstreet Capital Limited Partnership significantly increased its stake in Bristol Myers Squibb Company by 31.1% in the third quarter, now owning 14,833,977 shares valued at $669.01 million. Other institutional investors have also adjusted their positions in the biopharmaceutical company, which shows a strong institutional ownership of 76.41%. The article also details Bristol Myers Squibb’s stock performance, recent earnings, upcoming dividend, and mixed analyst ratings, with a consensus “Hold” rating and an average price target of $61.00.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.